FDA Approves Opioid 1,000x Stronger Than Morphine

The FDA says that Dsuvia is necessary to provide pain relief to soldiers, but critics are wary of a drug that powerful.

Dsuvia Single Dose Packaging / Image: Dsuvia
Dsuvia Single Dose Packaging / Image: Dsuvia

A recent Popular Science article discussed a new ultra-powerful drug that just received FDA approval. Dsuvia, formulated by AcelRX Pharmaceuticals, is a new form of a drug called sufentanil, which is reportedly a 10-times more powerful version of fentanyl. It comes in a 30-microgram tablet that is taken under the tongue via a special applicator that dispenses a single dose.

According to FDA commissioner Scot Gottlieb, Dsuvia won’t be sold in retail pharmacies, and will only be administered in “medically-supervised health care settings.” He went on to say that the special single-dose applicator will help prevent accidental overdose. The FDA’s Anesthetic and Analgesic Drug Product Advisory Committee voted in favor of the drug in October, and the agency approved it on November 2nd. It should hit the market in early 2019.

Sustainable Healthcare Packaging Solutions That Work
Industry leaders share proven strategies for reducing packaging emissions by up to 70% while meeting safety and regulatory requirements.
Read More
Sustainable Healthcare Packaging Solutions That Work
Have You Heard About our Podcasts?
Through the Line podcasts explore innovations and information across the packaging and processing landscape. Join us for the latest insights, trends, and strategies shaping packaging and processing today.
Listen Today
Have You Heard About our Podcasts?